Bank Of America Corp Gilead Sciences, Inc. Transaction History

Bank Of America Corp

$1.21 Trillion
Q1 2025

A detailed history of Bank Of America Corp transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Bank Of America Corp holds 18,352,837 shares of GILD stock, worth $2 Billion. This represents 0.17% of its overall portfolio holdings.

Number of Shares

18,352,837

Previous 17,717,680 3.58%

Holding current value

$2 Billion

Previous $1.64 Billion 25.65%

% of portfolio

0.17%

Previous 0.14%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	BUY	$89.14 - $117.41 $56.6 Million - $74.6 Million	635,157 Added 3.58%	18,352,837 $2.06 Billion
Q4 2024 Feb 14, 2025	BUY	$83.95 - $97.9 $880 Million - $1.03 Billion	10,487,673 Added 145.06%	17,717,680 $1.64 Billion
Q3 2024 Nov 14, 2024	BUY	$66.59 - $83.99 $36.9 Million - $46.6 Million	554,777 Added 8.31%	7,230,007 $606 Million
Q2 2024 Aug 14, 2024	BUY	$63.15 - $72.88 $3.71 Million - $4.28 Million	58,754 Added 0.89%	6,675,230 $458 Million
Q1 2024 May 15, 2024	BUY	$71.58 - $87.29 $11 Million - $13.4 Million	154,019 Added 2.38%	6,616,476 $485 Million
Q4 2023 Feb 14, 2024	BUY	$73.27 - $83.09 $79.4 Million - $90 Million	1,083,125 Added 20.13%	6,462,457 $524 Million
Q2 2023 Aug 14, 2023	SELL	$76.01 - $86.7 $176 Million - $201 Million	-2,319,931 Reduced 30.13%	5,379,332 $415 Million
Q1 2023 May 12, 2023	BUY	$77.31 - $88.08 $8.93 Million - $10.2 Million	115,510 Added 1.52%	7,699,263 $639 Million
Q4 2022 Feb 10, 2023	BUY	$62.32 - $89.47 $37.5 Million - $53.8 Million	601,855 Added 8.62%	7,583,753 $651 Million
Q3 2022 Nov 14, 2022	SELL	$59.54 - $68.01 $22.8 Million - $26.1 Million	-383,246 Reduced 5.2%	6,981,898 $431 Million
Q2 2022 Aug 12, 2022	SELL	$57.72 - $65.01 $23.4 Million - $26.3 Million	-405,094 Reduced 5.21%	7,365,144 $455 Million
Q1 2022 May 16, 2022	BUY	$57.92 - $72.58 $44.1 Million - $55.3 Million	762,250 Added 10.88%	7,770,238 $462 Million
Q4 2021 Feb 08, 2022	SELL	$64.88 - $73.64 $42.5 Million - $48.2 Million	-654,527 Reduced 8.54%	7,007,988 $509 Million
Q3 2021 Nov 15, 2021	BUY	$67.69 - $73.03 $35.8 Million - $38.6 Million	528,382 Added 7.41%	7,662,515 $535 Million
Q2 2021 Sep 13, 2021	BUY	$63.47 - $69.35 $453 Million - $495 Million	7,134,133 New	7,134,133 $491 Million

Others Institutions Holding GILD

# of Institutions

2,286

Shares Held

997M

Call Options Held

9.62M

Put Options Held

10M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $137B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.

Account

Bank Of America Corp Gilead Sciences, Inc. Transaction History